Your browser doesn't support javascript.
loading
Dosimetry of [212Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free 208Tl on Tissue Absorbed Doses.
Orcutt, Kelly D; Henry, Kelly E; Habjan, Christine; Palmer, Keryn; Heimann, Jack; Cupido, Julie M; Gottumukkala, Vijay; Cissell, Derek D; Lyon, Morgan C; Hussein, Amira I; Liu, Dijie; Li, Mengshi; Johnson, Frances L; Schultz, Michael K.
Afiliação
  • Orcutt KD; Viewpoint Molecular Targeting, Inc., Coralville, IA 52241, USA.
  • Henry KE; Invicro, LLC, Needham, MA 02494, USA.
  • Habjan C; Invicro, LLC, Needham, MA 02494, USA.
  • Palmer K; Invicro, LLC, Needham, MA 02494, USA.
  • Heimann J; Invicro, LLC, Needham, MA 02494, USA.
  • Cupido JM; Invicro, LLC, Needham, MA 02494, USA.
  • Gottumukkala V; Invicro, LLC, Needham, MA 02494, USA.
  • Cissell DD; Invicro, LLC, Needham, MA 02494, USA.
  • Lyon MC; Invicro, LLC, Needham, MA 02494, USA.
  • Hussein AI; Invicro, LLC, Needham, MA 02494, USA.
  • Liu D; Viewpoint Molecular Targeting, Inc., Coralville, IA 52241, USA.
  • Li M; Viewpoint Molecular Targeting, Inc., Coralville, IA 52241, USA.
  • Johnson FL; Viewpoint Molecular Targeting, Inc., Coralville, IA 52241, USA.
  • Schultz MK; Viewpoint Molecular Targeting, Inc., Coralville, IA 52241, USA.
Molecules ; 27(18)2022 Sep 08.
Article em En | MEDLINE | ID: mdl-36144563

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor Tipo 1 de Melanocortina / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor Tipo 1 de Melanocortina / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article